Company / EPS (Diluted)
Chemed Corp. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$17.93
FY2025
5-year range
$13.31 / $19.48
FY2021-FY2025
Trend
+8.5%
vs FY2024
Sector context
#8 of 159
Health Care
What the data says
Among 159 Health Care companies, Chemed Corp. is in the top 5% for eps (diluted). EPS (Diluted) returned to growth in FY2025 after 2 years of decline, reaching $17.93.
Based on SEC 10-K filings.
17.93 in FY2025 with a 5-year CAGR of +8.0%. Top quartile in the Health Care sector.
Improved from $16.85 to $17.93 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -2.7%
- 5-Year CAGR
- +8.0%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 159This company $17.93 Sector average $1.64
▼
+994.3% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 8.5% year-over-year.
- Ranks #8 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2022.
- Lowest eps (diluted) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.70 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.93 | +8.5% |
| FY2024 | $16.53 | -1.9% |
| FY2023 | $16.85 | -13.5% |
| FY2022 | $19.48 | +46.4% |
| FY2021 | $13.31 | +8.8% |
| FY2020 | $12.23 | +108.7% |
| FY2019 | $5.86 | -9.6% |
| FY2018 | $6.48 | +2.4% |
| FY2017 | $6.33 | +13.6% |
| FY2016 | $5.57 | +33.9% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026